INNOVATE BIOPHARMACEUTICLS I
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for INNOVATE BIOPHARMACEUTICLS I CALL, CUSIP 45782F905.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for INNOVATE BIOPHARMACEUTICLS I CALL, CUSIP 45782F905.